CADTH has completed its Therapeutic Review update of second-line therapies for patients with type 2 diabetes. The following reports are now available on the CADTH website:
- final science report on second-line therapy (clinical and economic evaluations)
- final recommendations report on second-line therapy
- In Brief — a summary of the project including key messages
- Project Protocol
- Patient Input
Work is underway at CADTH on the third-line therapy review. Stay tuned for opportunities to provide feedback.
For more information, visit the project page at www.cadth.ca/newdrugst2dm.